PHARMACYTE BIOTECH, INC. Operating Income
PHARMACYTE BIOTECH, INC. (PMCB) reported Operating Income of -$1.01 million for the 3-month period ending 2026-07-31, per its 10-Q filed 2026-09-14.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-09-14
- PHARMACYTE BIOTECH, INC. operating income (loss) for the quarter ending 2026-07-31 was -$1.01M.
- PHARMACYTE BIOTECH, INC. operating income (loss) for the quarter ending 2026-04-30 was -$2.51M.
- PHARMACYTE BIOTECH, INC. operating income (loss) for the quarter ending 2026-01-31 was -$2.12M.
- PHARMACYTE BIOTECH, INC. operating income (loss) for the quarter ending 2025-10-31 was -$1.38M.
- PHARMACYTE BIOTECH, INC. operating income (loss) for fiscal 2026 was -$6.85M.
- PHARMACYTE BIOTECH, INC. operating income (loss) for fiscal 2025 was -$4.38M.
- PHARMACYTE BIOTECH, INC. operating income (loss) for fiscal 2024 was -$8.52M.
- PHARMACYTE BIOTECH, INC. operating income (loss) for fiscal 2023 was -$6.46M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-07-31 | -$1.01M 10-Q · filed 2026-09-14 | -$3.52M derived: sum of 2 quarters · filed 2026-09-14 | -$5.64M derived: sum of 3 quarters · filed 2026-09-14 | -$7.01M derived: sum of 4 quarters · filed 2026-09-14 | |||
| 2026-04-30 | -$2.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | -$4.63M derived: sum of 2 quarters · filed 2026-07-29 | -$6.01M derived: sum of 3 quarters · filed 2026-07-29 | -$6.85M 10-K · filed 2026-07-29 | |||
| 2026-01-31 | -$2.12M 10-Q · filed 2026-03-17 | -$3.49M derived: sum of 2 quarters · filed 2026-03-17 | -$4.34M 10-Q · filed 2026-03-17 | -$5.38M derived: sum of 4 quarters · filed 2026-09-14 | |||
| 2025-10-31 | -$1.38M 10-Q · filed 2025-12-18 | -$2.22M 10-Q · filed 2025-12-18 | -$3.27M derived: sum of 3 quarters · filed 2026-09-14 | -$4.23M derived: sum of 4 quarters · filed 2026-09-14 | |||
| 2025-07-31 | -$848.30K 10-Q · filed 2026-09-14 | -$1.89M derived: sum of 2 quarters · filed 2026-09-14 | -$2.85M derived: sum of 3 quarters · filed 2026-09-14 | -$3.96M derived: sum of 4 quarters · filed 2026-09-14 | |||
| 2025-04-30 | -$1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-29 | -$2.00M derived: sum of 2 quarters · filed 2026-07-29 | -$3.11M derived: sum of 3 quarters · filed 2026-07-29 | -$4.38M 10-K · filed 2026-07-29 | |||
| 2025-01-31 | -$960.25K 10-Q · filed 2026-03-17 | -$2.07M derived: sum of 2 quarters · filed 2026-03-17 | -$3.34M 10-Q · filed 2026-03-17 | -$6.50M derived: sum of 4 quarters · filed 2026-03-17 | |||
| 2024-10-31 | -$1.11M 10-Q · filed 2025-12-18 | -$2.37M 10-Q · filed 2025-12-18 | -$5.54M derived: sum of 3 quarters · filed 2025-12-18 | -$7.41M derived: sum of 4 quarters · filed 2025-12-18 | |||
| 2024-07-31 | -$1.27M 10-Q · filed 2025-09-15 | -$4.44M derived: sum of 2 quarters · filed 2025-09-15 | -$6.30M derived: sum of 3 quarters · filed 2025-09-15 | -$7.71M derived: sum of 4 quarters · filed 2025-09-15 | |||
| 2024-04-30 | -$3.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-11 | -$5.04M derived: sum of 2 quarters · filed 2025-08-11 | -$6.44M derived: sum of 3 quarters · filed 2025-08-11 | -$8.52M 10-K · filed 2025-08-11 | |||
| 2024-01-31 | -$1.87M 10-Q · filed 2025-03-17 | -$3.28M derived: sum of 2 quarters · filed 2025-03-17 | -$5.35M 10-Q · filed 2025-03-17 | -$6.26M derived: sum of 4 quarters · filed 2025-03-17 | |||
| 2023-10-31 | -$1.41M 10-Q · filed 2024-12-13 | -$3.48M 10-Q · filed 2024-12-13 | -$4.39M derived: sum of 3 quarters · filed 2024-12-13 | -$5.94M derived: sum of 4 quarters · filed 2024-12-13 | |||
| 2023-07-31 | -$2.08M 10-Q · filed 2024-09-17 | -$2.98M derived: sum of 2 quarters · filed 2024-09-17 | -$4.53M derived: sum of 3 quarters · filed 2024-09-17 | -$6.85M derived: sum of 4 quarters · filed 2024-09-17 | |||
| 2023-04-30 | -$903.28K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-13 | -$2.46M derived: sum of 2 quarters · filed 2024-08-13 | -$4.77M derived: sum of 3 quarters · filed 2024-08-13 | -$6.46M 10-K · filed 2024-08-13 | |||
| 2023-01-31 | -$1.55M 10-Q · filed 2024-03-18 | -$3.87M derived: sum of 2 quarters · filed 2024-03-18 | -$5.55M 10-Q · filed 2024-03-18 | -$7.06M derived: sum of 4 quarters · filed 2024-03-18 | |||
| 2022-10-31 | -$2.32M 10-Q · filed 2023-12-15 | -$4.00M 10-Q · filed 2023-12-15 | -$5.51M derived: sum of 3 quarters · filed 2023-12-15 | -$6.36M derived: sum of 4 quarters · filed 2023-12-15 | |||
| 2022-07-31 | -$1.68M 10-Q · filed 2023-09-18 | -$3.19M derived: sum of 2 quarters · filed 2023-09-18 | -$4.04M derived: sum of 3 quarters · filed 2023-09-18 | -$5.05M derived: sum of 4 quarters · filed 2023-09-18 | |||
| 2022-04-30 | -$1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-31 | -$2.36M derived: sum of 2 quarters · filed 2023-07-31 | -$3.37M derived: sum of 3 quarters · filed 2023-07-31 | -$4.39M 10-K · filed 2023-07-31 | |||
| 2022-01-31 | -$856.12K 10-Q · filed 2023-03-16 | -$1.86M derived: sum of 2 quarters · filed 2023-03-16 | -$2.88M 10-Q · filed 2023-03-16 | -$3.92M derived: sum of 4 quarters · filed 2023-03-16 | |||
| 2021-10-31 | -$1.00M 10-Q · filed 2022-12-14 | -$2.03M 10-Q · filed 2022-12-14 | -$3.06M derived: sum of 3 quarters · filed 2022-12-14 | -$3.82M derived: sum of 4 quarters · filed 2022-12-14 | |||
| 2021-07-31 | -$1.02M 10-Q · filed 2022-09-14 | -$2.06M derived: sum of 2 quarters · filed 2022-09-14 | -$2.82M derived: sum of 3 quarters · filed 2022-09-14 | -$3.76M derived: sum of 4 quarters · filed 2022-09-14 | |||
| 2021-04-30 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-28 | -$1.79M derived: sum of 2 quarters · filed 2022-07-28 | -$2.74M derived: sum of 3 quarters · filed 2022-07-28 | -$3.62M 10-K · filed 2022-07-28 | |||
| 2021-01-31 | -$756.85K 10-Q · filed 2022-03-15 | -$1.71M derived: sum of 2 quarters · filed 2022-03-15 | -$2.59M 10-Q · filed 2022-03-15 | -$3.34M derived: sum of 4 quarters · filed 2022-03-15 | |||
| 2020-10-31 | -$949.51K 10-Q · filed 2021-12-14 | -$1.83M 10-Q · filed 2021-12-14 | -$2.58M derived: sum of 3 quarters · filed 2021-12-14 | -$3.46M derived: sum of 4 quarters · filed 2021-12-14 | |||
| 2020-07-31 | -$881.68K 10-Q · filed 2021-09-14 | -$1.63M derived: sum of 2 quarters · filed 2021-09-14 | -$2.51M derived: sum of 3 quarters · filed 2021-09-14 | -$3.57M derived: sum of 4 quarters · filed 2021-09-14 | |||
| 2020-04-30 | -$749.89K derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-10 | -$1.63M derived: sum of 2 quarters · filed 2021-08-10 | -$2.69M derived: sum of 3 quarters · filed 2021-08-10 | -$3.83M 10-K · filed 2021-08-10 | |||
| 2020-01-31 | -$875.31K 10-Q · filed 2021-03-12 | -$1.94M derived: sum of 2 quarters · filed 2021-03-12 | -$3.08M 10-Q · filed 2021-03-12 | -$4.25M derived: sum of 4 quarters · filed 2021-03-12 | |||
| 2019-10-31 | -$1.07M 10-Q · filed 2020-12-11 | -$2.20M 10-Q · filed 2020-12-11 | -$3.37M derived: sum of 3 quarters · filed 2020-12-11 | -$4.05M derived: sum of 4 quarters · filed 2020-12-11 | |||
| 2019-07-31 | -$1.13M 10-Q · filed 2020-09-11 | -$2.31M derived: sum of 2 quarters · filed 2020-09-11 | -$2.98M derived: sum of 3 quarters · filed 2020-09-11 | -$4.02M derived: sum of 4 quarters · filed 2020-09-11 | |||
| 2019-04-30 | -$1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-13 | -$1.85M derived: sum of 2 quarters · filed 2020-08-13 | -$2.89M derived: sum of 3 quarters · filed 2020-08-13 | -$4.10M 10-K · filed 2020-08-13 | |||
| 2019-01-31 | -$676.35K 10-Q · filed 2020-03-13 | -$1.71M derived: sum of 2 quarters · filed 2020-03-13 | -$2.93M 10-Q · filed 2020-03-13 | -$4.38M derived: sum of 4 quarters · filed 2020-03-13 | |||
| 2018-10-31 | -$1.04M 10-Q · filed 2019-12-23 | -$2.25M 10-Q · filed 2019-12-23 | -$3.70M derived: sum of 3 quarters · filed 2019-12-23 | -$5.73M derived: sum of 4 quarters · filed 2019-12-23 | |||
| 2018-07-31 | -$1.22M 10-Q · filed 2019-09-13 | -$2.66M derived: sum of 2 quarters · filed 2019-09-13 | -$4.69M derived: sum of 3 quarters · filed 2019-09-13 | -$6.51M derived: sum of 4 quarters · filed 2019-09-13 | |||
| 2018-04-30 | -$1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-13 | -$3.48M derived: sum of 2 quarters · filed 2019-08-13 | -$5.29M derived: sum of 3 quarters · filed 2019-08-13 | -$6.98M 10-K · filed 2019-08-13 | |||
| 2018-01-31 | -$2.03M 10-Q · filed 2019-03-14 | -$3.84M derived: sum of 2 quarters · filed 2019-03-14 | -$5.53M 10-Q · filed 2019-03-14 | -$6.69M derived: sum of 4 quarters · filed 2019-03-14 | |||
| 2017-10-31 | -$1.81M 10-Q · filed 2018-12-14 | -$3.50M 10-Q · filed 2018-12-14 | -$4.66M derived: sum of 3 quarters · filed 2018-12-14 | -$5.94M derived: sum of 4 quarters · filed 2018-12-14 | |||
| 2017-07-31 | -$1.69M 10-Q · filed 2018-09-12 | -$2.84M derived: sum of 2 quarters · filed 2018-09-12 | -$4.12M derived: sum of 3 quarters · filed 2018-09-12 | -$5.10M derived: sum of 4 quarters · filed 2018-09-12 | |||
| 2017-04-30 | -$1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-20 | -$2.44M derived: sum of 2 quarters · filed 2018-07-20 | -$3.41M derived: sum of 3 quarters · filed 2018-07-20 | -$4.44M 10-K · filed 2018-07-20 | |||
| 2017-01-31 | -$1.28M 10-Q · filed 2018-03-19 | -$2.26M derived: sum of 2 quarters · filed 2018-03-19 | -$3.29M 10-Q · filed 2018-03-19 | -$4.42M derived: sum of 4 quarters · filed 2018-03-19 | |||
| 2016-10-31 | -$974.20K 10-Q · filed 2017-12-14 | -$2.01M 10-Q · filed 2017-12-14 | -$3.14M derived: sum of 3 quarters · filed 2017-12-14 | -$4.93M derived: sum of 4 quarters · filed 2017-12-14 | |||
| 2016-07-31 | -$1.03M 10-Q · filed 2017-09-13 | -$2.16M derived: sum of 2 quarters · filed 2017-09-13 | -$3.95M derived: sum of 3 quarters · filed 2017-09-13 | -$5.59M derived: sum of 4 quarters · filed 2017-09-13 | |||
| 2016-04-30 | -$1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-27 | -$2.92M derived: sum of 2 quarters · filed 2017-07-27 | -$4.56M derived: sum of 3 quarters · filed 2017-07-27 | -$6.07M 10-K · filed 2017-07-27 | |||
| 2016-01-31 | -$1.79M 10-Q · filed 2017-03-13 | -$3.43M derived: sum of 2 quarters · filed 2017-03-13 | -$4.94M 10-Q · filed 2017-03-13 | -$8.92M derived: sum of 4 quarters · filed 2017-03-13 | |||
| 2015-10-31 | -$1.64M 10-Q · filed 2016-12-02 | -$1.13M 10-Q · filed 2015-12-10 | -$3.15M 10-Q · filed 2016-12-02 | -$2.14M 10-Q · filed 2015-12-10 | -$7.13M derived: sum of 3 quarters · filed 2016-12-02 | -$8.58M derived: sum of 4 quarters · filed 2016-12-02 | |
| 2015-07-31 | -$1.51M 10-Q · filed 2016-09-06 | -$1.01M 10-Q · filed 2015-08-25 | -$5.49M derived: sum of 2 quarters · filed 2016-09-06 | -$6.95M derived: sum of 3 quarters · filed 2016-09-06 | -$13.19M derived: sum of 4 quarters · filed 2016-09-06 | ||
| 2015-04-30 | -$3.98M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | -$5.43M derived: sum of 2 quarters · filed 2016-07-29 | -$11.68M derived: sum of 3 quarters · filed 2016-07-29 | -$13.26M 10-K · filed 2016-07-29 | -$13.70M 10-K · filed 2015-07-29 | ||
| 2015-01-31 | -$1.46M 10-Q · filed 2016-03-08 | -$7.70M derived: sum of 2 quarters · filed 2016-03-08 | -$9.29M 10-Q · filed 2016-03-08 | -$25.73M derived: sum of 4 quarters · filed 2016-07-29 | |||
| 2014-10-31 | -$6.25M 10-Q/A · filed 2016-01-19 | -$7.83M 10-Q/A · filed 2016-01-19 | -$24.28M derived: sum of 3 quarters · filed 2016-07-29 | -$24.96M derived: sum of 4 quarters · filed 2016-07-29 | |||
| 2014-07-31 | -$1.58M 10-Q/A · filed 2016-01-19 | -$18.03M derived: sum of 2 quarters · filed 2016-07-29 | -$18.71M derived: sum of 3 quarters · filed 2016-07-29 | -$19.16M derived: sum of 4 quarters · filed 2016-07-29 | |||
| 2014-04-30 | -$16.45M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | -$17.13M derived: sum of 2 quarters · filed 2016-07-29 | -$17.58M derived: sum of 3 quarters · filed 2016-07-29 | -$18.98M 10-K · filed 2016-07-29 | |||
| 2014-01-31 | -$681.08K 10-Q · filed 2015-03-13 | -$1.13M derived: sum of 2 quarters · filed 2015-03-13 | -$2.53M 10-Q · filed 2015-03-13 | -$2.99M derived: sum of 4 quarters · filed 2016-01-19 | |||
| 2013-10-31 | -$448.57K 10-Q · filed 2014-12-15 | -$1.85M 10-Q · filed 2014-12-15 | -$2.30M derived: sum of 3 quarters · filed 2016-01-19 | -$2.65M derived: sum of 4 quarters · filed 2016-01-19 | |||
| 2013-07-31 | -$1.40M 10-Q · filed 2014-09-15 | -$1.86M derived: sum of 2 quarters · filed 2016-01-19 | -$2.20M derived: sum of 3 quarters · filed 2016-01-19 | -$2.55M derived: sum of 4 quarters · filed 2016-01-19 | |||
| 2013-04-30 | -$455.19K derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-01-19 | -$796.03K derived: sum of 2 quarters · filed 2016-01-19 | -$1.14M derived: sum of 3 quarters · filed 2016-01-19 | -$1.68M 10-K/A · filed 2016-01-19 | |||
| 2013-01-31 | -$340.84K 10-Q · filed 2014-03-17 | -$689.64K derived: sum of 2 quarters · filed 2014-03-17 | -$1.23M 10-Q · filed 2014-03-17 | -$1.71M derived: sum of 4 quarters · filed 2014-03-17 | |||
| 2012-10-31 | -$348.80K 10-Q · filed 2013-12-16 | -$887.58K 10-Q · filed 2013-12-16 | -$1.37M derived: sum of 3 quarters · filed 2013-12-16 | -$1.78M derived: sum of 4 quarters · filed 2013-12-16 | |||
| 2012-07-31 | -$538.79K 10-Q · filed 2013-09-16 | -$1.02M derived: sum of 2 quarters · filed 2013-09-16 | -$1.43M derived: sum of 3 quarters · filed 2013-09-16 | -$1.84M derived: sum of 4 quarters · filed 2013-09-16 | |||
| 2012-04-30 | -$482.87K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-29 | -$892.85K derived: sum of 2 quarters · filed 2013-07-29 | -$1.30M derived: sum of 3 quarters · filed 2013-07-29 | -$1.95M 10-K · filed 2013-07-29 | |||
| 2012-01-31 | -$409.98K 10-Q · filed 2013-03-26 | -$813.71K derived: sum of 2 quarters · filed 2013-03-26 | -$1.47M 10-Q · filed 2013-03-26 | ||||
| 2011-10-31 | -$403.73K 10-Q · filed 2012-12-26 | -$1.06M 10-Q · filed 2012-12-26 | |||||
| 2011-07-31 | -$652.60K 10-Q · filed 2012-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |